KKR Clinches $400 Million Deal To Take Controlling Stake In India's Cancer Hospital Chain HCG: Details
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
KKR Acquires Stake in Healthcare Global Enterprises: KKR & Co. Inc. has entered into agreements to become the largest shareholder of Healthcare Global Enterprises (HCG) by acquiring up to 54% equity for $400 million, with plans to increase ownership to 54%-77% through an open offer to public shareholders.
Focus on Indian Healthcare Sector: This investment aligns with KKR's strategy to enhance medical infrastructure and oncology services in India, following previous investments in various healthcare-related companies through its Asia Fund IV.
Analyst Views on LBO
Wall Street analysts forecast LBO stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for LBO is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 29.452
Low
Averages
High
Current: 29.452
Low
Averages
High
No data
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
